AFRY strengthens Life Science presence in Germany
Connecting local market insight with international engineering capabilities
As Europe strengthens its pharmaceutical manufacturing capacity to enhance competitiveness and supply security, demand across the Life Science sector continues to grow. Against this backdrop, AFRY is strengthening its presence in Germany by establishing dedicated local Life Science leadership and a client focused organization.
As part of AFRY’s expanded presence, Tabea Martins has been appointed Head of Segment Life Science Germany. She brings more than 18 years of experience in the pharmaceutical and biotechnology industry, spanning complex capital projects, engineering and project delivery, client development and leadership.
She will be joined by Helmut Steudel, who will support business development and sales activities across Europe, with an initial focus on Germany and the wider Austrian and Swiss market. He brings extensive senior leadership experience, deep knowledge of the international pharmaceutical and Life Science market and a strong client network.
I am excited to welcome Tabea Martins and Helmut Steudel. By establishing this local team with deep market knowledge, AFRY is well positioned to support clients with complex engineering and project management needs across the full project lifecycle
said Jessica Stenberg, Head of Segment Life Science at AFRY.
Germany is one of Europe's largest and most established Life Science markets, R&D and innovation hub and manufacturing backbone in the industry as well as home to a broad range of global pharmaceutical and biotech companies.
Germany combines a strong pharmaceutical and biotech manufacturing base with significant demand for modernisation, capacity expansion and more sustainable, digital production. Our ambition is to provide our clients with strong local support for their Life Science projects, utilizing the full breadth of AFRY’s engineering capabilities in Germany and across our international network
said Tabea Martins Head of Life Science Germany.
About AFRY’s Life Science offering
In the latest Engineering News Record (ENR) ranking in 2025, AFRY was listed as the world's fifth-largest engineering and design company in the pharmaceuticals sector, based on revenue generated outside its home market. The expansion into Germany is a natural next step in AFRY's strategy to follow its customers internationally and pursue sustainable growth in global markets.
